1. Home
  2. HTHT vs MEDP Comparison

HTHT vs MEDP Comparison

Compare HTHT & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H World Group Limited

HTHT

H World Group Limited

HOLD

Current Price

$49.03

Market Cap

13.6B

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$619.05

Market Cap

15.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTHT
MEDP
Founded
2005
1992
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
15.4B
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
HTHT
MEDP
Price
$49.03
$619.05
Analyst Decision
Strong Buy
Hold
Analyst Count
4
12
Target Price
$56.60
$473.17
AVG Volume (30 Days)
1.6M
242.8K
Earning Date
05-19-2026
04-22-2026
Dividend Yield
4.07%
N/A
EPS Growth
N/A
20.98
EPS
N/A
8.53
Revenue
N/A
N/A
Revenue This Year
$7.18
$13.19
Revenue Next Year
$6.71
$7.75
P/E Ratio
$30.34
$71.99
Revenue Growth
N/A
N/A
52 Week Low
$35.69
$373.00
52 Week High
$56.53
$677.90

Technical Indicators

Market Signals
Indicator
HTHT
MEDP
Relative Strength Index (RSI) 69.82 62.91
Support Level $47.34 $567.90
Resistance Level $50.62 $627.59
Average True Range (ATR) 1.29 16.85
MACD 0.71 -0.19
Stochastic Oscillator 96.59 73.84

Price Performance

Historical Comparison
HTHT
MEDP

About HTHT H World Group Limited

H World Group Ltd a foremost, fast-growing multi-brand hotel group with international operations. The principal business activities of the Company are to develop and operate leased and owned, manachised and franchised hotels mainly in the PRC or PRC Mainland. The Group has two operating segments which are legacy Huazhu and legacy DH according to the way management intends to evaluate results and allocate resources within the Group. The majority of revenue comes from legacy Huazhu. The company has presence in Greater China and also Outside Greater China.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: